36 related articles for article (PubMed ID: 25313589)
21. A randomized, double-blind study of pegylated liposomal doxorubicin for the treatment of AIDS-related Kaposi's sarcoma.
Cooley T; Henry D; Tonda M; Sun S; O'Connell M; Rackoff W
Oncologist; 2007 Jan; 12(1):114-23. PubMed ID: 17227906
[TBL] [Abstract][Full Text] [Related]
22. [Tinnitus in a Patient Treated by Bleomycin for Kaposi's Sarcoma].
Laschinski B; Arnault JP; Gras-Champel V
Therapie; 2015; 70(6):539-40. PubMed ID: 26220920
[TBL] [Abstract][Full Text] [Related]
23. [Cutaneous angiosarcoma : Radiochemotherapy with liposomal pegylated doxorubicin].
Bönisch N; Langan EA; Terheyden P
Hautarzt; 2019 Sep; 70(9):700-706. PubMed ID: 31428802
[TBL] [Abstract][Full Text] [Related]
24. Treatments for classic Kaposi sarcoma: a systematic review of the literature.
Régnier-Rosencher E; Guillot B; Dupin N
J Am Acad Dermatol; 2013 Feb; 68(2):313-31. PubMed ID: 22695100
[TBL] [Abstract][Full Text] [Related]
25. Spontaneous healing of Kaposi's angiosarcoma of the penis.
Casado M; Jimenez F; Borbujo J; Almagro M
J Urol; 1988 Jun; 139(6):1313-5. PubMed ID: 3286894
[TBL] [Abstract][Full Text] [Related]
26. Triple secondary neoplasms: penis, lip and oral cavity in an AIDS patient treated with pegylated liposomal doxorubicin for cutaneous Kaposi's sarcoma.
Volkow P; Lizano M; Carrillo-García A; Pérez-Montiel D; Garciadiego P
AIDS; 2014 Sep; 28(15):2327-9. PubMed ID: 25313589
[No Abstract] [Full Text] [Related]
27. Pegylated liposomal doxorubicin: a review of its use in metastatic breast cancer, ovarian cancer, multiple myeloma and AIDS-related Kaposi's sarcoma.
Duggan ST; Keating GM
Drugs; 2011 Dec; 71(18):2531-58. PubMed ID: 22141391
[TBL] [Abstract][Full Text] [Related]
28. Total resolution of ocular Kaposi sarcoma with different treatment approaches - a case series and review of literature.
Yeak J; Iqbal T; Zahari M; Ismail F
Int J STD AIDS; 2019 Jul; 30(8):802-809. PubMed ID: 31046617
[No Abstract] [Full Text] [Related]
29. Role of pegylated lyposomal doxorubicin (PLD) in systemic Kaposi's sarcoma: a systematic review.
Di Trolio R; Di Lorenzo G; Delfino M; De Placido S
Int J Immunopathol Pharmacol; 2006; 19(2):253-63. PubMed ID: 16831292
[TBL] [Abstract][Full Text] [Related]
30. Pegylated liposomal doxorubicin: a guide to its use in various malignancies.
Lyseng-Williamson KA; Duggan ST; Keating GM
BioDrugs; 2013 Oct; 27(5):533-40. PubMed ID: 24018470
[TBL] [Abstract][Full Text] [Related]
31. Liposomal doxorubicin.
Linsky KF; Ignoffo RJ
Cancer Pract; 1996; 4(5):288-90. PubMed ID: 9004577
[No Abstract] [Full Text] [Related]
32.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
